203 related articles for article (PubMed ID: 24786126)
1. Circulating cell-free DNA in sickle cell disease: is it a potentially useful biomarker?
Al-Humood S; Zueriq R; Al-Faris L; Marouf R; Al-Mulla F
Arch Pathol Lab Med; 2014 May; 138(5):678-83. PubMed ID: 24786126
[TBL] [Abstract][Full Text] [Related]
2. Soluble CD163 in young sickle cell disease patients and their trait siblings: a biomarker for pulmonary hypertension and vaso-occlusive complications.
Tantawy AA; Adly AA; Ismail EA
Blood Coagul Fibrinolysis; 2012 Oct; 23(7):640-8. PubMed ID: 22885767
[TBL] [Abstract][Full Text] [Related]
3. Circulating DNA: a potential marker of sickle cell crisis.
Vasavda N; Ulug P; Kondaveeti S; Ramasamy K; Sugai T; Cheung G; Rees DC; Awogbade M; Bannister S; Cunningham J; Menzel S; Thein SL
Br J Haematol; 2007 Oct; 139(2):331-6. PubMed ID: 17897311
[TBL] [Abstract][Full Text] [Related]
4. Relevance of fibrinolytic protein (D-dimer) and fibrinopeptide A as markers of sickle cell anaemia vaso-occlusive crisis.
Ekwere TA; Ebele U; Ekanem M; Ogunro PS
Niger Postgrad Med J; 2014 Sep; 21(3):225-30. PubMed ID: 25331238
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of copeptin, C-reactive protein and cortisol in different severity groups of sickle cell anaemia.
Akinlade KS; Atere AD; Rahamon SK; Olaniyi JA
Niger J Physiol Sci; 2013 Dec; 28(2):159-64. PubMed ID: 24937391
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary function studies in Kuwaiti children with sickle cell disease and elevated Hb F.
Hijazi Z; Onadeko BO; Khadadah M; Haider MZ; Adekile AD; Al-Habashi H
Int J Clin Pract; 2005 Feb; 59(2):163-7. PubMed ID: 15854191
[TBL] [Abstract][Full Text] [Related]
7. The influence of foetal haemoglobin on the frequency of vaso-occlusive crisis in sickle cell anaemia patients.
Enosolease ME; Ejele OA; Awodu OA
Niger Postgrad Med J; 2005 Jun; 12(2):102-5. PubMed ID: 15997258
[TBL] [Abstract][Full Text] [Related]
8. Influence of crisis on haemoglobin F level in adult Nigerian sickle cell anaemia patients.
Olatunji PO; Falusi AG; Esien EM
Cent Afr J Med; 1992 Jun; 38(6):242-6. PubMed ID: 1382859
[TBL] [Abstract][Full Text] [Related]
9. Chronic inflammatory state in sickle cell anemia patients is associated with HBB(*)S haplotype.
Bandeira IC; Rocha LB; Barbosa MC; Elias DB; Querioz JA; Freitas MV; Gonçalves RP
Cytokine; 2014 Feb; 65(2):217-21. PubMed ID: 24290434
[TBL] [Abstract][Full Text] [Related]
10. Elevated plasma levels and platelet-associated expression of the pro-thrombotic and pro-inflammatory protein, TNFSF14 (LIGHT), in sickle cell disease.
Garrido VT; Proença-Ferreira R; Dominical VM; Traina F; Bezerra MA; de Mello MR; Colella MP; Araújo AS; Saad ST; Costa FF; Conran N
Br J Haematol; 2012 Sep; 158(6):788-97. PubMed ID: 22775554
[TBL] [Abstract][Full Text] [Related]
11. Cytokine profile of sickle cell disease in Oman.
Pathare A; Al Kindi S; Alnaqdy AA; Daar S; Knox-Macaulay H; Dennison D
Am J Hematol; 2004 Dec; 77(4):323-8. PubMed ID: 15551290
[TBL] [Abstract][Full Text] [Related]
12. Hydroxyurea in sickle cell disease--a study of clinico-pharmacological efficacy in the Indian haplotype.
Italia K; Jain D; Gattani S; Jijina F; Nadkarni A; Sawant P; Nair S; Mohanty D; Ghosh K; Colah R
Blood Cells Mol Dis; 2009; 42(1):25-31. PubMed ID: 18954999
[TBL] [Abstract][Full Text] [Related]
13. Exacerbation of oxidative stress during sickle vaso-occlusive crisis is associated with decreased anti-band 3 autoantibodies rate and increased red blood cell-derived microparticle level: a prospective study.
Hierso R; Lemonne N; Villaescusa R; Lalanne-Mistrih ML; Charlot K; Etienne-Julan M; Tressières B; Lamarre Y; Tarer V; Garnier Y; Hernandez AA; Ferracci S; Connes P; Romana M; Hardy-Dessources MD
Br J Haematol; 2017 Mar; 176(5):805-813. PubMed ID: 27984639
[TBL] [Abstract][Full Text] [Related]
14. Magnetic Resonance Imaging Assessment of Kidney Oxygenation and Perfusion During Sickle Cell Vaso-occlusive Crises.
Deux JF; Audard V; Brugières P; Habibi A; Manea EM; Guillaud-Danis C; Godeau B; Galactéros F; Stehlé T; Lang P; Grimbert P; Audureau E; Rahmouni A; Bartolucci P
Am J Kidney Dis; 2017 Jan; 69(1):51-59. PubMed ID: 27663041
[TBL] [Abstract][Full Text] [Related]
15. Altered levels of pro-inflammatory cytokines in sickle cell disease patients during vaso-occlusive crises and the steady state condition.
Keikhaei B; Mohseni AR; Norouzirad R; Alinejadi M; Ghanbari S; Shiravi F; Solgi G
Eur Cytokine Netw; 2013 Mar; 24(1):45-52. PubMed ID: 23608554
[TBL] [Abstract][Full Text] [Related]
16. Fibrinolytic activity in adult Kenyan patients with sickle cell disease.
Aluoch JR
East Afr Med J; 1998 Jun; 75(6):351-2. PubMed ID: 9803619
[TBL] [Abstract][Full Text] [Related]
17. Sickle cell vaso-occlusive crisis is associated with abnormalities in the ratio of vasoconstrictor to vasodilator prostanoids.
Setty BN; Chen D; Stuart MJ
Pediatr Res; 1995 Jul; 38(1):95-102. PubMed ID: 7478805
[TBL] [Abstract][Full Text] [Related]
18. Changes in platelet count as a predictive tool in sickle cell acute vaso-occlusive crises: a pediatric study.
Shanley LA; Ebeling M; Titus MO
Clin Pediatr (Phila); 2011 Jul; 50(7):657-61. PubMed ID: 21382920
[TBL] [Abstract][Full Text] [Related]
19. Overview of pathophysiology and rationale for treatment of sickle cell anemia.
Rodgers GP
Semin Hematol; 1997 Jul; 34(3 Suppl 3):2-7. PubMed ID: 9317195
[TBL] [Abstract][Full Text] [Related]
20. Circulating platelet and erythrocyte microparticles in young children and adolescents with sickle cell disease: Relation to cardiovascular complications.
Tantawy AA; Adly AA; Ismail EA; Habeeb NM; Farouk A
Platelets; 2013; 24(8):605-14. PubMed ID: 23249216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]